UBS lowered the firm’s price target on Gartner to $510 from $550. While Q1 CV was disappointing, UBS keeps a Buy rating on the shares as as the firm expects CV growth to re-accelerate in Q2 and Q3 and its conviction in margin upside increases with the Q1 beat and raise, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IT: